In the combined therapy group and the medication group , the levels of 5-HT , IL-4 and IL-10 in 4 weeks of treatment were all increased as compared with those before treatment ( all P < 0.01 ) , and the levels of IL-1 and IL-6 were lower than those before treatment ( all P < 0.01 ) .